This clinical trial aims to assess the effectiveness of different clinical techniques in treating patients with chronic low back pain (CLBP). Two test groups will be included: one receiving conventional therapy (NSAIDs and other physical therapy techniques) and the other receiving a combination of neuromodulation and platelet-rich plasma (PRP) therapy. Chronic pain, persisting for more than three months, inhibits natural pathways like GABA and promotes excitatory pathways, leading to increased inflammation. The study hypothesizes that neuromodulation via the dorsal root ganglion (DRG) and PRP therapy will provide superior pain relief and functional improvement compared to conventional therapy.
Adults aged 40-60 years.
Diagnosed with chronic low back pain persisting for more than three months.
Willingness to participate and comply with study procedures.
Ability to provide informed consent.
Comorbidities.
Contagious and Non-Contagious Infections
Known hypersensitivity to study interventions.
Presence of severe psychiatric disorders.